درباره این اپیزود
This episode covers three research papers relevant to postmenopausal health: a Chinese study on whether a DNA-based cervical screening test performs differently after menopause, a clarification on a vitamin D drug used for bone thinning, and a cross-sectional study on whether dental imaging can flag low bone density before a formal bone scan is ever ordered.
Key Takeaways:
• A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
• Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
• A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
• The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
• All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References:
• PAX1 and JAM3 methylation for cervical screening in pre- vs. postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42830604/) - PubMed
• Eldecalcitol and calcium supplementation for postmenopausal osteoporosis: author reply (https://pubmed.ncbi.nlm.nih.gov/42830322/) - PubMed
• Dental CT scan gray values as a predictor of bone density in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42829977/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-10-05-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
• Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
• A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
• The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
• All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References:
• PAX1 and JAM3 methylation for cervical screening in pre- vs. postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42830604/) - PubMed
• Eldecalcitol and calcium supplementation for postmenopausal osteoporosis: author reply (https://pubmed.ncbi.nlm.nih.gov/42830322/) - PubMed
• Dental CT scan gray values as a predictor of bone density in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42829977/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-10-05-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Hot Flasher را جستجو کن.
قسمت های دیگر در این پادکست
Three new papers landed this week, and they're all quietly about cardiovascular risk in postmenopausal women — from how we read heart scans, to how dietary fat affects cholesterol and gut health, to why doctors still aren't getting enough training on menopause. This episode breaks down what the res…
The American College of Physicians released a major new clinical guideline on medications for hot flashes and night sweats — and it has real implications for what treatment options your doctor will offer. This episode also covers the underreported connection between early menopause and anxiety and …
JAMA just dedicated a full special issue to menopause and chronic pain — a real signal that the research world is starting to take this seriously. This episode also covers two symptoms that often fly under the radar: dry eyes linked to estrogen decline, and changes in body odor that many women noti…
This episode covers new research linking early menopause to higher cognitive risk, a 12-month study showing HRT reduces hand joint pain in perimenopausal women, and a USA Today look at whether pairing scientists with social media influencers is a real solution to menopause misinformation.
Key Take…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Hot Flasher است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم